pemigatinib
innovent biologics,incyte
['pemazyre', 'pemigatinib', 'innovent', '$ivbxf']
$ivbxf new article : innovent announces overall survival results of phase 2 study of pemazyre (pemigatinib) in chinese patients with advanced cholangiocarcinoma presented at aacr annual meeting 2023 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.